Xenon
Manufacturing · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3650 Gilmore Way Ste 200, Burnaby, Briti...Phone Number
(604) 484-3300Website
www.xenon-pharma.comRevenue
-Stock Symbol
XENEIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Xenon
Xenon is a clinical stage biopharmaceutical company founded in 1996 and headquartered in Canada. The company focuses on developing innovative therapeutics for patients with neurological disorders, particularly rare central nervous system conditions. Xenon specializes in creating novel neurology therapies that address areas of high unmet medical need, with a primary focus on treatments for epilepsy. The company maintains a product pipeline aimed at improving quality of life for patients with various neurological conditions through pharmaceutical innovation.Explore more
Xenon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xenon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Xenon is spiking on competitors!
Earning: See what the market has to say on Xenon recently announced quarterly report
Click to see if Xenon had a recent Job posting/layoffs
Check if Xenon has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Xenon
Xenon, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Xenon launches new products
Funding: Get notified immidiatlly once Xenon has new funding data
Recommended Actions
Reach out to Masked Content who joined Xenon as Masked Content
Find 3 more new buyers
Compare Similar Companies to Xenon
Compare insights from companies similar to Xenon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Xenon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xenon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xenon.
Xenon financials insights
Gather financial insights about Xenon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Corporate Investment
$5.3M
2014
Stock Offering
$38.2M
2016
Stock Offering
$25.9M
2018
Stock Offering
$50M
Stock Offering
$63M
2019
Corporate Investment
$50M
2020
Stock Offering
$69M
Xenon Tech Stack
A closer look at the technologies used by Xenon
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Xenon News & Media
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions.Xenon Pharmaceuticals Inc. (XENE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Xenon Pharmaceuticals Inc. (XENE) Bank of America Global Healthcare Conference 2026 May 14, 2026 11:00 AM EDTCompany ParticipantsThomas Kelly - Chief...Xenon Pharmaceuticals Q1 Earnings Call Highlights
Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to submit a new drug application to the U.S. Food and Drug Administration in the third quarter of 2026 for azetukalner, its investigational anti-seizure medicine, after reporting positive Phase 3 data in focal onset seizures during the first qXenon Pharmaceuticals Inc. (XENE) Q1 2026 Earnings Call Transcript
Xenon Pharmaceuticals Inc. (XENE) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDTCompany ParticipantsColleen Alabiso - Senior Vice President of Corporate...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Xenon
Sign Up For FreeTo access detailed company insights
Xenon is a clinical stage biopharmaceutical company founded in 1996 and headquartered in Canada. The company focuses on developing innovative therapeutics for patients with neurological disorders, particularly rare central nervous system conditions. Xenon specializes in creating novel neurology therapies that address areas of high unmet medical nee... Read More
